158 related articles for article (PubMed ID: 9106629)
1. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells.
Gargalidis-Moudanos C; Remaury A; Pizzinat N; Parini A
Mol Pharmacol; 1997 Apr; 51(4):637-43. PubMed ID: 9106629
[TBL] [Abstract][Full Text] [Related]
2. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
Remaury A; Ordener C; Shih J; Parini A
Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
[TBL] [Abstract][Full Text] [Related]
3. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
4. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A
J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297
[TBL] [Abstract][Full Text] [Related]
5. I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
Gargalidis-Moudanos C; Pizzinat N; Javoy-Agid F; Remaury A; Parini A
Neurochem Int; 1997 Jan; 30(1):31-6. PubMed ID: 9116585
[TBL] [Abstract][Full Text] [Related]
6. Localization of I2-imidazoline binding sites on monoamine oxidases.
Tesson F; Limon-Boulez I; Urban P; Puype M; Vandekerckhove J; Coupry I; Pompon D; Parini A
J Biol Chem; 1995 Apr; 270(17):9856-61. PubMed ID: 7730367
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
8. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B.
Raddatz R; Parini A; Lanier SM
J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]idazoxan binding proteins in solubilized membranes from rabbit and human liver.
Remaury A; Missy K; Parini A
J Auton Nerv Syst; 1998 Oct; 72(2-3):111-7. PubMed ID: 9851559
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
Gargalidis-Moudanos C; Parini A
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
[TBL] [Abstract][Full Text] [Related]
11. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
[TBL] [Abstract][Full Text] [Related]
12. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
13. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of imidazoline I2 binding sites in pig brain.
Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
[TBL] [Abstract][Full Text] [Related]
16. Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites.
Sastre M; García-Sevilla JA
J Neurochem; 1993 Sep; 61(3):881-9. PubMed ID: 8395564
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
18. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
Raddatz R; Lanier SM
Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
[TBL] [Abstract][Full Text] [Related]
19. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
McDonald GR; Olivieri A; Ramsay RR; Holt A
Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
[TBL] [Abstract][Full Text] [Related]
20. Modulation of MAO activity by imidazoline and guanidine derivatives.
Raasch W; Muhle H; Dominiak P
Ann N Y Acad Sci; 1999 Jun; 881():313-31. PubMed ID: 10415932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]